Sandra Catalina Hoyos Orozco

Mr. Sandra Catalina Hoyos Orozco

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
SOSandra Catalina Hoyos Orozco
Sandra Catalina Hoyos Orozco
Lili BecerraLili Becerra
Lili Becerra
Diego QuirogaDiego Quiroga
Diego Quiroga
A pseudo-multicomponent one-pot protocol for the synthesis of 1,3-disubstituted imidazolidin-2-one is described, employing trans-(R,R)-diaminocyclohexane for the in situ formation of the Schiff base, followed by reduction to produce the respective diamine and cyclization with carbonyldiimidazole (CDI). This approach utilizes statistical analysis to optimize the reaction conditions, allowing a pseudo-multicomponent protocol to be proposed. The developed method demonstrates sustainability, efficiency, and potential applications in green chemistry, achieving yields ranging from 55% to 81%. This represents a significant advance in synthesizing heterocyclic compounds with biological and pharmacological applications.


4 June 2026 in Molbank
Verified
Journal Article
Open access
PDF file
SOSandra Catalina Hoyos Orozco
Sandra Catalina Hoyos Orozco
Ericsson Coy-BarreraEricsson Coy-Barrera
Ericsson Coy-Barrera
Diego QuirogaDiego Quiroga
Diego Quiroga
Imidazolidin-2-thiones are versatile sulfur-containing heterocycles with broad biological relevance. The synthesis of (3aR,7aR)-1,3-bis(4-aminobenzyl)octahydro-2H-benzo[d]imidazole-2-thione (an imidazolidin-2-thione derivative) from trans-(R, R)-diaminocyclohexane is presented via a three-step sequence: formation of a Schiff base from 1,2-diamine and 4-nitrobenzaldehyde, followed by reduction with NaBH4; thiocarbonylation under microwave irradiation (MW) to generate the imidazolidin-2-thione core; and reduction of the nitro substituents to amines using an iron/CaCl2 system. The structure of the final compound was confirmed by detailed 1H and 13C NMR analyses, demonstrating the preservation of the bicyclic backbone and the successful conversion of the nitro functional group. The overall yield of the sequence was 28%, with the reduction of the nitro group identified as the rate-limiting step. This protocol represents a viable synthetic strategy for obtaining functionalized imidazolidin-2-thiones useful for the development of novel bioactive sulfur-containing heterocycles.